-

Fujifilm to Highlight Cutting-Edge Imaging Innovations at RSNA 2025

New diagnostic imaging solutions to increase operational efficiencies and optimize patient care

LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leader in diagnostic and enterprise imaging solutions, will highlight its latest diagnostic imaging innovations in booth #3300 in South Hall at the Radiological Society of North America (RSNA) 2025 annual meeting, held November 30 to December 3 at McCormick Place in Chicago. These new imaging advances are built for today’s demanding clinical environments, delivering intelligent mobile bedside imaging, unique Deep Learning MRI applications, high resolution surgical guidance and fully automated radiographic room efficiency.

“Fujifilm’s mission is to deliver imaging systems that not only meet the performance demands of the most challenging procedures, but also streamline workflows, reduce dose, and elevate the patient and clinician experience,” said Shawn Etheridge, executive director, modality solutions marketing, FUJIFILM Healthcare Americas Corporation. “RSNA 2025 gives us the opportunity to engage directly with clinicians on how Fujifilm’s solutions are delivering on that promise.”

Among the new innovations to be demonstrated at the booth:

  • AI-powered MRI image quality and workflow enhancements: DLR Symmetry leverages deep learning reconstruction to optimize image quality while reducing scan times using partial Fourier techniques. Additionally, AutoPose with AI extends automatic slice selection to chest, cardiac, pelvis and lower extremities improving precision, accelerating workflow and promoting consistent, repeatable imaging across a broader range of exams.
  • FDR Go iQ Portable Digital Radiography System: Fujifilm’s latest intelligent DR portable built for busy radiology departments is equipped with an intuitive tube head touch display and convenient in-bin detector smart charging. An intelligent built-in 3D camera provides live positioning guidance and tube to bed angulation and auto sensing SID display. FDR Go iQ brings x-ray room image quality to bedside exams.
  • Persona C-HR Mobile Fluoroscopy C-Arm: 25 kW power, high-sensitivity detector, and 82 cm wide opening combines to deliver high-resolution imaging at low dose. Designed for demanding OR workflows, Persona C-HR offers 30 fps pulsed fluoroscopy, active cooling, dedicated surgeon’s console with high resolution 32”, 4k display and a secondary tech display and controls, for advanced vascular capabilities in a lightweight, surgeon-friendly design.
  • FDR Visionary Digital Radiography Suite: Fujifilm’s flagship, auto-positioning room now features a collimator-integrated camera for live visual positioning guidance and workflow acceleration. The system’s automation intelligence delivers impressive speed and repeatability for efficient, faster workflow and options for automated advanced applications including long length imaging at the chest stand and table, bone subtraction and tomosynthesis.

Attendees of RSNA 2025 will be able to talk directly with Fujifilm’s experts to learn how these technologies integrate into busy imaging departments, long-length imaging suites, OR environments, and portable/mobile use cases.

For more information about our presence at RSNA, click here, or follow us on LinkedIn and X for #RSNA25 updates throughout the event.

About Fujifilm

FUJIFILM Healthcare Americas Corporation is a comprehensive healthcare company that has an extensive range of technology and expertise in the detection, diagnosis, and treatment of diseases. Fujifilm’s innovative portfolio includes solutions spanning diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in-vitro diagnostics. The Non-Destructive Testing group delivers radiography solutions to ensure high accuracy inspection of transportation infrastructure, and assets within aerospace, and oil and gas industries.

The company is headquartered in Lexington, Massachusetts. For more information on healthcare offerings, please visit https://healthcaresolutions-us.fujifilm.com, and for NDT portfolio, please visit https://www.fujifilm.com/us/en/business/industrial-materials/non-destructive-testing.

FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen. For more information, please visit: https://holdings.fujifilm.com/en.

Contacts

Marissa Confredo
FUJIFILM Holdings America Corporation
marissa.confredo@fujifilm.com
914-343-4761

FUJIFILM Healthcare Americas Corporation


Release Versions

Contacts

Marissa Confredo
FUJIFILM Holdings America Corporation
marissa.confredo@fujifilm.com
914-343-4761

More News From FUJIFILM Healthcare Americas Corporation

Fujifilm Adds Second Cinema Power Zoom to GF Lens Lineup: FUJINON GF19-35mmT3.5 PZ OIS WR

VALHALLA, N.Y.--(BUSINESS WIRE)--FUJIFILM North America Corporation, Electronic Imaging Division, today announced the release of FUJINON GF19-35mmT3.5 PZ OIS WR (“GF19-35mmT3.5”), the second FUJINON cinema power zoom lens for the GFX System. With a native G Mount, GF19-35mmT3.5 provides the widest angle of view available in the GF format, offering filmmakers at all levels of production a large format cinema zoom with expanded cinematic versatility and exceptional optical performance in a compac...

FUJIFILM Biotechnologies Selected in FDA PreCheck Pilot Program to Advance U.S. Drug Manufacturing

HOLLY SPRINGS, N.C.--(BUSINESS WIRE)--FUJIFILM Biotechnologies (Fujifilm), a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced that its commercial-scale cell culture manufacturing facility in Holly Springs, North Carolina, has been selected as one of only seven participants in the U.S. Food and Drug Administration's (FDA) PreCheck Pilot Program. The program is a strategic initiative designed to strengthen Am...

FUJIFILM QuickSnap™ One-Time Use Cameras Celebrate 40 years with New Product Announcements

VALHALLA, N.Y.--(BUSINESS WIRE)--FUJIFILM North America Corporation, Imaging Division, is celebrating the 40th anniversary of the introduction of its QuickSnap™ one-time use camera line with the introduction of two new varieties of its popular portable camera lineup – QuickSnap Black and White™, and QuickSnap Active™, which replaces the current waterproof QuickSnap™ camera. “For 40 years, FUJIFILM QuickSnap™ cameras have been trusted companions for people making images on the go,” said Bing Lie...
Back to Newsroom